Should hyperlipidaemia in dialysis patients be treated?

Nephrology Dialysis Transplantation

Volumn 12, Issue 1, 1997, Pages 19-21

  Wheeler, D C ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

CARDIOVASCULAR RISK; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSIS; EDITORIAL; HUMAN; HYPERLIPIDEMIA; PRIORITY JOURNAL;

ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; HUMANS; HYPERLIPIDEMIAS; KIDNEY FAILURE, CHRONIC; LIPID METABOLISM; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL REPLACEMENT THERAPY; RISK FACTORS;

EID: 0031013574     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.1.19     Document Type: Editorial

References (10)